These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 31115106

  • 1. Comparison of the predictive value among inflammation-based scoring systems for bleomycin pulmonary toxicity in patients with germ cell tumors.
    Maruyama Y, Sadahira T, Araki M, Mitsui Y, Wada K, Edamura K, Kobayashi Y, Watanabe M, Watanabe T, Nasu Y.
    Int J Urol; 2019 Aug; 26(8):813-819. PubMed ID: 31115106
    [Abstract] [Full Text] [Related]

  • 2. Comparison of inflammation-based prognostic scores as predictors of survival outcomes in patients with germ cell tumors.
    Yoshinaga K, Sadahira T, Maruyama Y, Mitsui Y, Iwata T, Wada K, Araki M, Watanabe T, Nasu Y.
    Investig Clin Urol; 2021 Jan; 62(1):47-55. PubMed ID: 33314803
    [Abstract] [Full Text] [Related]

  • 3. Prognostic impact of bleomycin pulmonary toxicity on the outcomes of patients with germ cell tumors.
    Maruyama Y, Sadahira T, Mitsui Y, Araki M, Wada K, Tanimoto R, Kobayashi Y, Watanabe M, Watanabe T, Nasu Y.
    Med Oncol; 2018 Apr 26; 35(6):80. PubMed ID: 29700638
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Modified-BEP Chemotherapy in Patients With Germ-Cell Tumors Treated at a Comprehensive Cancer Center.
    Aurilio G, Verri E, Frassoni S, Bagnardi V, Cossu Rocca M, Cullurà D, Milani M, Mascia R, Curigliano G, Orsi F, Jereczek-Fossa BA, Musi G, Omodeo Salè E, De Cobelli O, Nolè F.
    Am J Clin Oncol; 2020 Jun 26; 43(6):381-387. PubMed ID: 32079853
    [Abstract] [Full Text] [Related]

  • 8. Bleomycin-Induced Pulmonary Changes on Restaging Computed Tomography Scans in Two Thirds of Testicular Cancer Patients Show No Correlation With Fibrosis Markers.
    den Hollander MW, Westerink ND, Lubberts S, Bongaerts AH, Wolf RF, Altena R, Nuver J, Oosting SF, de Vries EG, Walenkamp AM, Meijer C, Gietema JA.
    Oncologist; 2016 Aug 26; 21(8):995-1001. PubMed ID: 27328932
    [Abstract] [Full Text] [Related]

  • 9. Frequency and risk factors of bleomycin-induced pulmonary toxicity in South Indian patients with germ-cell tumors.
    Thakkar DN, Ramasamy K, Adithan S, Selvarajan S, Dubashi B.
    J Cancer Res Ther; 2021 Aug 26; 17(2):443-449. PubMed ID: 34121690
    [Abstract] [Full Text] [Related]

  • 10. High-risk germ cell tumors in men. High response rate and severe toxicity with cisplatin, vinblastine, bleomycin, and etoposide.
    Blayney DW, Goldberg DA, Leong LA, Margolin KA, Burke JS, Doroshow JH.
    Cancer; 1993 Apr 01; 71(7):2351-7. PubMed ID: 7680946
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bleomycin lung toxicity detected by technetium-99m diethylene triamine penta-acetic acid aerosol scintigraphy.
    Ugur O, Caner B, Balbay MD, Ozen HA, Remzi D, Ulutuncel N, Bekdik C.
    Eur J Nucl Med; 1993 Feb 01; 20(2):114-8. PubMed ID: 7679991
    [Abstract] [Full Text] [Related]

  • 15. Ambulatory infusion of bleomycin in patients receiving chemotherapy for germ cell tumors.
    Green JA, Hammond P, Watkin SW.
    Sel Cancer Ther; 1989 Feb 01; 5(2):93-5. PubMed ID: 2475900
    [No Abstract] [Full Text] [Related]

  • 16. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
    Bosl GJ, Geller NL, Bajorin D, Leitner SP, Yagoda A, Golbey RB, Scher H, Vogelzang NJ, Auman J, Carey R.
    J Clin Oncol; 1988 Aug 01; 6(8):1231-8. PubMed ID: 2457657
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Survival and toxicity in patients with disseminated germ cell cancer aged 40 years and older.
    Thomsen FB, Bandak M, Thomsen MF, Lauritsen J, Christensen IJ, Daugaard G.
    Cancer; 2014 Jan 01; 120(1):43-51. PubMed ID: 24108413
    [Abstract] [Full Text] [Related]

  • 20. Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy.
    Vidal AD, Thalmann GN, Karamitopoulou-Diamantis E, Fey MF, Studer UE.
    Ann Oncol; 2015 Feb 01; 26(2):374-7. PubMed ID: 25392157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.